A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Jazz Pharmaceuticals (JAZZ) is back in the spotlight after reporting its strongest quarter on record, with Q4 2025 revenue of US$1.20b and 2026 guidance that aligns with market expectations. See our latest analysis for Jazz Pharmaceuticals. The earnings beat and in line 2026 revenue guidance have clearly reset expectations, with the share price up 13.23% over one day and a 36.53% total shareholder return over the past year suggesting momentum is building rather than fading. If this kind of move has you looking beyond a single company, it could be a good moment to check out our screener of 30 healthcare AI stocks as another way to spot emerging ideas in this corner of the market. With Jazz now trading near a record high after a 37% one-year return and analysts seeing further upside, the key question is whether the recent surge still leaves room for mispricing or
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals plc Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Royal Bank Of Canada from $191.00 to $195.00. They now have an "outperform" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Morgan Stanley from $225.00 to $226.00. They now have an "overweight" rating on the stock.MarketBeat
- Jazz Pharmaceuticals (JAZZ) had its price target raised by Wells Fargo & Company from $235.00 to $250.00. They now have an "overweight" rating on the stock.MarketBeat
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 2/24/26 - Form 10-K
- 2/24/26 - Form 8-K
- 1/21/26 - Form 4
- JAZZ's page on the SEC website